DAB2 and lung cancer: DAB2 is underexpressed in tumors compared to normal tissue and correlates with the malignant phenotype of lung cancer, urothelial carcinoma, squamous cell carcinoma, nasopharyngeal carcinoma, and esophageal squamous carcinoma [69–73].